COVID-19 in children with blood and cancer disorders: An experience from India

Impact of COVID19 on children with blood and cancer disorders

“…Cycle threshold (Ct) values of PCR test for COVID19 have wide variation and do not predict severity. Interestingly, 3 children in this study had reactivation/reinfection on restarting chemotherapy ( 6 ). One child being treated with Anti-CD20 monoclonal antibody, Rituximab took much longer time to clear the virus ( 6 ).…”

“…Now coming to impact of COVID19 on non-malignant hematological conditions in children, in this issue few reports have described this aspect also ( 4 , 5 , 6 , 7 , 8 , 10 , 11 , 12 ). Kakkar et al have reported a cohort of 14 patients with thalassemia and COVID19 patients of whom only 2 needed hospitalisation.…”